Devices for cell transplantation into the central nervous system: Design considerations and emerging technologies

Surgical Neurology International

Volumn 4, Issue SUPPL1, 2013, Pages

  Potts, Matthew B ^a   Silvestrini, Matthew T ^a   Lim, Daniel A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cell transplantation; Parkinson s disease; radially branched deployment; stereotactic injection

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BLOOD BRAIN BARRIER; BRAIN DEPTH STIMULATION; BRAIN GRAFT; BRAIN HEMATOMA; BRAIN ISCHEMIA; CATHETER; CATHETERIZATION; CELL DENSITY; CELL ENGINEERING; CELL TRANSFER; CELL TRANSPLANTATION; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; ELECTRODE IMPLANT; ENGRAFTMENT; GENERAL MEDICAL DEVICE; HUMAN; IMPLANT DELIVERY DEVICE; INTERVENTIONAL MAGNETIC RESONANCE IMAGING; MEDICAL RESEARCH; NONHUMAN; PARKINSON DISEASE; PATIENT SAFETY; PRIORITY JOURNAL; RADIALLY BRANCHED DEPLOYMENT DEVICE; RISK BENEFIT ANALYSIS; STEREOTACTIC PROCEDURE; SYRINGE NEEDLE; TRANSLATIONAL RESEARCH;

EID: 84877950633     PISSN: None     EISSN: 21527806     Source Type: Journal    
DOI: 10.4103/2152-7806.109190     Document Type: Article

References (85)

1. Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ. Structure and function of the blood-brain barrier. Neurobiol Dis 2010;37:13-25.
2. Aboody K, Capela A, Niazi N, Stern JH, Temple S. Translating stem cell studies to the clinic for CNS repair: Current state of the art and the need for a Rosetta stone. Neuron 2011;70:597-613.
3. Aboody KS, Brown A, Rainov NG, Bower KA, Liu S, Yang W, et al. Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas. Proc Natl Acad Sci USA 2000;97:12846-51.
4. Aguado BA, Mulyasasmita W, Su J, Lampe KJ, Heilshorn SC. Improving viability of stem cells during syringe needle flow through the design of hydrogel cell carriers. Tissue Eng Part A 2012;18:806-15.
5. Álvarez-Dolado M, Pardal R, García-Verdugo JM, Fike JR, Lee HO, Pfeffer K, et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 2003;425:968-73.
6. Bachoud-Lévi A, Bourdet C, Brugières P, Nguyen JP, Grandmougin T, Haddad B, et al. Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington′s disease. Exp Neurol 2000;161:194-202.
7. Bachoud-Lévi AC, Gaura V, Brugières P, Lefaucheur JP, Boissé MF, Maison P, et al. Effect of fetal neural transplants in patients with Huntington′s disease 6 years after surgery: A long-term follow-up study. Lancet Neurol 2006;5:303-9.
8. Bachoud-Lévi AC, Remy P, Nguyen JP, Brugières P, Lefaucheur JP, Bourdet C, et al. Motor and cognitive improvements in patients with Huntington′s disease after neural transplantation. Lancet 2000;356:1975-9.
9. Banks WA. Developing drugs that can cross the blood-brain barrier: Applications to Alzheimer′s disease. BMC Neurosci 2008;9 Suppl 3:S2.
10. Ben-Hur T. Cell therapy for multiple sclerosis. Neurotherapeutics 2011;8:625-42.
11. Benraiss A, Goldman SA. Cellular therapy and induced neuronal replacement for Huntington′s disease. Neurotherapeutics 2011;8:577-90.
12. Binder DK, Rau G, Starr PA. Hemorrhagic complications of microelectrode-guided deep brain stimulation. Stereotact Funct Neurosurg 2003;80:28-31.
13. Binder DK, Rau GM, Starr PA. Risk factors for hemorrhage during microelectrode-guided deep brain stimulator implantation for movement disorders. Neurosurgery 2005;56:722-32; discussion 722-32.
14. Bjarkam CR, Glud AN, Margolin L, Reinhart K, Franklin R, Deding D, et al. Safety and function of a new clinical intracerebral microinjection instrument for stem cells and therapeutics examined in the Göttingenminipig. Stereotact Funct Neurosurg 2010;88:56-63.
15. Bliss TM, Andres RH, Steinberg GK. Optimizing the success of cell transplantation therapy for stroke. Neurobiol Dis 2010;37:275-83.
16. Brazelton TR, Rossi FM, Keshet GI, Blau HM. From marrow to brain: Expression of neuronal phenotypes in adult mice. Science 2000;290:1775-9.
17. Brecknell JE, Fawcett JW. A device for the implantation of multiple cellular deposits into a large volume of brain from a single cannula site. Exp Neurol 1996;138:338-44.
18. Breeze RE, Wells TH Jr, Freed CR. Implantation of fetal tissue for the management of Parkinson′s disease: A technical note. Neurosurgery 1995;36:1044-7; discussion 1047-8.
19. Chiocca EA, Abbed KM, Tatter S, Louis DN, Hochberg FH, Barker F, et al. A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting. Mol Ther 2004;10:958-66.
20. Chiocca EA, Aguilar LK, Bell SD, Kaur B, Hardcastle J, Cavaliere R, et al. Phase IB study of gene-mediated cytotoxic immunotherapy adjuvant to up-front surgery and intensive timing radiation for malignant glioma. J Clin Oncol 2011;29:3611-9.
21. Cunningham MG, Bolay H, Scouten CW, Moore C, Jacoby D, Moskowitz M, et al. Preclinical evaluation of a novel intracerebral microinjection instrument permitting electrophysiologically guided delivery of therapeutics. Neurosurgery 2004;54:1497-507; discussion 1507.
22. Deda H, Inci MC, Kürekçi AE, Sav A, Kayihan K, Özgün E, et al. Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: A 1-year follow-up. Cytotherapy 2009;11:18-25.
23. Ding D, Kanaly CW, Bigner DD, Cummings TJ, Herndon JE, Pastan I, et al. Convection-enhanced delivery of free gadolinium with the recombinant immunotoxin MR1-1. J Neurooncol 2010;98:1-7.
24. Dunnett SB, Björklund A, Lindvall O. Cell therapy in Parkinson′s disease-stop or go? Nat Rev Neurosci 2001;2:365-9.
25. Feron F, Perry C, Cochrane J, Licina P, Nowitzke A, Urquhart S, et al. Autologous olfactory ensheathing cell transplantation in human spinal cord injury. Brain 2005;128:2951-60.
26. Fink JS, Schumacher JM, Ellias SL, Palmer EP, Saint-Hilaire M, Shannon K, et al. Porcine xenografts in Parkinson′s disease and Huntington′s disease patients: Preliminary results. Cell Transplant 2000;9:273-8.
27. Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, Kao R, et al. Transplantation of embryonic dopamine neurons for severe Parkinson′s disease. N Engl J Med 2001;344:710-9.
28. Friedrich MA, Martins MP, Araújo MD, Klamt C, Vedolin L, Garicochea B, et al. Intra-arterial infusion of autologous bone marrow mononuclear cells in patients with moderate to severe middle cerebral artery acute ischemic stroke. Cell Transplant 2012;21 Suppl 1:S13-21.
29. Gallina P, Paganini M, Di Rita A, Lombardini L, Moretti M, Vannelli GB, et al. Human fetal striatal transplantation in huntington′s disease: A refinement of the stereotactic procedure. Stereotact Funct Neurosurg 2008;86:308-13.
30. Goldman S. Stem and progenitor cell-based therapy of the human central nervous system. Nat Biotechnol 2005;23:862-71.
31. Hall JE, Guyton AC. Guyton and Hall Textbook of Medical Physiology. 12 th ed. Philadelphia: Saunders. 2011.
32. Harrow S, Papanastassiou V, Harland J, Mabbs R, Petty R, Fraser M, et al. HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: Safety data and long-term survival.Gene Ther 2004;11:1648-58.
33. Hauser RA, Furtado S, Cimino CR, Delgado H, Eichler S, Schwartz S, et al. Bilateral human fetal striatal transplantation in Huntington′s disease. Neurology 2002;58:687-95.
34. Huang H, Chen L, Wang H, Xiu B, Li B, Wang R, et al. Influence of patients′ age on functional recovery after transplantation of olfactory ensheathing cells into injured spinal cord injury. Chin Med J (Engl) 2003;116:1488-91.
35. Joyce N, Annett G, Wirthlin L, Olson S, Bauer G, Nolta JA. Mesenchymal stem cells for the treatment of neurodegenerative disease. Regen Med 2010;5:933-46.
36. Kidd S, Spaeth E, Dembinski JL, Dietrich M, Watson K, Klopp A, et al. Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging. Stem Cells 2009;27:2614-23.
37. Knoller N, Auerbach G, Fulga V, Zelig G, Attias J, Bakimer R, et al. Clinical experience using incubated autologous macrophages as a treatment for complete spinal cord injury: Phase I study results. J Neurosurg Spine 2005;3:173-81.
38. Kondziolka D. Device for cell delivery into the brain or body. Patent number# US 20080132878A1, June 5, 2008.
39. Kondziolka D, Steinberg GK, Wechsler L, Meltzer CC, Elder E, Gebel J, et al. Neurotransplantation for patients with subcortical motor stroke: A phase 2 randomized trial. J Neurosurg 2005;103:38-45.
40. Kopyov OV, Jacques DS, Lieberman A, Duma CM, Rogers RL. Outcome following intrastriatal fetal mesencephalic grafts for Parkinson′s patients is directly related to the volume of grafted tissue. Exp Neurol 1997;146:536-45.
41. Krauze MT, Mcknight TR, Yamashita Y, Bringas J, Noble CO, Saito R, et al. Real-time visualization and characterization of liposomal delivery into the monkey brain by magnetic resonance imaging. Brain Res Brain Res Protoc 2005;16:20-6.
42. Krauze MT, Saito R, Noble C, Bringas J, Forsayeth J, Mcknight TR, et al. Effects of the perivascular space on convection-enhanced delivery of liposomes in primate putamen. Exp Neurol 2005;196:104-111.
43. Larson PS, Starr PA, Bates G, Tansey L, Richardson RM, Martin AJ. An optimized system for interventional magnetic resonance imaging-guided stereotactic surgery: Preliminary evaluation of targeting accuracy. Neurosurgery 2012;70:95-103; discussion 103.
44. Lim JY, Jeong CH, Jun JA, Kim SM, Ryu CH, Hou Y, et al. Therapeutic effects of human umbilical cord blood-derived mesenchymal stem cells after intrathecal administration by lumbar puncture in a rat model of cerebral ischemia. Stem Cell Res Ther 2011;2:38.
45. Lindvall O, Björklund A. Cell therapy in Parkinson′s disease. Neuro Rx 2004;1:382-93.
46. Lindvall O, Kokaia Z. Stem cells in human neurodegenerative disorders-time for clinical translation? J Clin Invest 2010;120:29-40.
47. Liu Y, Huang HY. Treatment of spinal cord injury by transplantation of cells via cerebrospinal fluid. Neurosci Bull 2008;24:323-8.
48. Mackay-Sim A, Feron F, Cochrane J, Bassingthwaighte L, Bayliss C, Davies W, et al. Autologous olfactory ensheathing cell transplantation in human paraplegia: A 3-year clinical trial. Brain 2008;131:2376-86.
49. Madrazo I, Franco-Bourland RE, Castrejon H, Cuevas C, Ostrosky-Solis F. Fetal striatal homotransplantation for Huntington′s disease: First two case reports. Neurol Res 1995;17:312-5.
50. Mazzini L, Ferrero I, Luparello V, Rustichelli D, Gunetti M, Mareschi K, et al. Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial. Exp Neurol 2010;223:229-37.
51. Mendez I, Hong M, Smith S, Dagher A, Desrosiers J. Neural transplantation cannula and microinjector system: Experimental and clinical experience. Technical note. J Neurosurg 2000;92:493-9.
52. Mendez I, Sanchez-Pernaute R, Cooper O, Viñuela A, Ferrari D, Björklund L, et al. Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson′s disease. Brain 2005;128:1498-510.
53. Mezey E, Chandross KJ, Harta G, Maki RA, McKercher SR. Turning blood into brain: Cells bearing neuronal antigens generated in vivo from bone marrow. Science 2000;290:1779-82.
54. Misra V, Lal A, EI Khoury R, Chen PR, Savitz SI. Intra-arterial delivery of cell therapies for stroke. Stem Cells Dev 2012;21:1007-15.
55. Morrison PF, Chen MY, Chadwick RS, Lonser RR, Oldfield EH. Focal delivery during direct infusion to brain: Role of flow rate, catheter diameter, and tissue mechanics. Am J Physiol 1999;277 (4 Pt 2):R1218-29.
56. Motaln H, Schichor C, Lah TT. Human mesenchymal stem cells and their use in cell-based therapies. Cancer 2010;116:2519-30.
57. Nicholson C. Diffusion and related transport mechanisms in brain tissue. Rep Prog Phys 2001:815-84.
58. Oh JS, Park IS, Kim KN, Yoon do H, Kim SH, Ha Y. Transplantation of an adipose stem cell cluster in a spinal cord injury. Neuroreport 2012;23:277-82.
59. Olanow CW, Goetz CG, Kordower JH, Stoessl AJ, Sossi V, Brin MF, et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson′s disease. Ann Neurol 2003;54:403-14.
60. Pardridge WM, Boado RJ. Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier. Methods Enzymol 2012;503:269-92.
61. Perry VH, Andersson PB, Gordon S. Macrophages and inflammation in the central nervous system. Trends Neurosci 1993;16:268-73.
62. Philpott LM, Kopyov OV, Lee AJ, Jacques S, Duma CM, Caine S, et al. Neuropsychological functioning following fetal striatal transplantation in Huntington′s chorea: Three case presentations. Cell Transplant 1997;6:203-12.
63. Raore B, Federici T, Taub J, Wu MC, Riley J, Franz CK, et al. Cervical multilevel intraspinal stem cell therapy: Assessment of surgical risks in Gottingen minipigs. Spine (Phila Pa 1976) 2011;36:E164-71.
64. Reuter I, Tai YF, Pavese N, Chaudhuri KR, Mason S, Polkey CE, et al. Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington′s disease. J Neurol Neurosurg Psychiatry 2008;79:948-51.
65. Richardson RM, Barbaro NM, Alvarez-Buylla A, Baraban SC. Developing cell transplantation for temporal lobe epilepsy. Neurosurg Focus 2008;24:E17.
66. Richardson RM, Kells AP, Martin AJ, Larson PS, Starr PA, Piferi PG, et al. Novel platform for MRI-guided convection-enhanced delivery of therapeutics: Preclinical validation in nonhuman primate brain. Stereotact Funct Neurosurg 2011;89:141-51.
67. Riley J, Federici T, Polak M, Kelly C, Glass J, Raore B, et al. Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: A phase I safety trial, technical note and lumbar safety outcomes. Neurosurgery 2012;71:405-16.
68. Riley JP, Raore B, Taub JS, Federici T, Boulis NM. Platform and cannula design improvements for spinal cord therapeutics delivery. Neurosurgery 2011;69:ons147-54; discussion ons155.
69. Rosser AE, Barker RA, Harrower T, Watts C, Farrington M, Ho AK, et al. Unilateral transplantation of human primary fetal tissue in four patients with Huntington′s disease: NEST-UK safety report ISRCTN no 36485475. J Neurol Neurosurg Psychiatry 2002;73:678-85.
70. Savitz SI, Dinsmore J, Wu J, Henderson GV, Stieg P, Caplan LR. Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: A preliminary safety and feasibility study. Cerebrovasc Dis 2005;20:101-7.
71. Schumacher JM, Ellias SA, Palmer EP, Kott HS, Dinsmore J, Dempsey PK, et al. Transplantation of embryonic porcine mesencephalic tissue in patients with PD. Neurology 2000;54:1042-50.
72. Selden NR, Guillaume DJ, Huhn SL, Koch TK, Al-Uzri A, Steiner RD. CNS transplantation of purified neural stem cells in neuronal ceroid lipofuscinoses: Phase I trial. American Association of Neurological Surgeons Annual Meeting; Philadelphia, PA, 2010.
73. Shand N, Weber F, Mariani L, Bernstein M, Gianella-Borradori A, Long Z, et al. A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group. Hum Gene Ther 1999;10:2325-35.
74. Silvestrini MT, Yin D, Coppes VG, Mann P, Martin AJ, Larson PS, et al. Radially branched deployment for more efficient cell transplantation at the scale of the human brain. Stereotact Funct Neurosurg 2013;91:92-103.
75. Skuk D, Paradis M, Goulet M, Tremblay JP. Ischemic central necrosis in pockets of transplanted myoblasts in nonhuman primates: Implications for cell-transplantation strategies. Transplantation 2007;84:1307-15.
76. Starr PA, Martin AJ, Ostrem JL, Talke P, Levesque N, Larson PS. Subthalamic nucleus deep brain stimulator placement using high-field interventional magnetic resonance imaging and a skull-mounted aiming device: Technique and application accuracy. J Neurosurg 2010;112:479-90.
77. Stilley CS, Ryan CM, Kondziolka D, Bender A, DeCesare S, Wechsler L. Changes in cognitive function after neuronal cell transplantation for basal ganglia stroke. Neurology 2004;63:1320-2.
78. Terada N, Hamazaki T, Oka M, Hoki M, Mastalerz DM, Nakano Y, et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 2002;416:542-5.
79. Tol M, Akar A, Durdu S, Ayyildiz E, Ilhan O. Comparison of different needle diameters and flow rates on bone marrow mononuclear stem cell viability: An ex vivo experimental study. Cytotherapy 2008;10:98-9.
80. Tuszynski MH, Thal L, Pay M, Salmon DP, U HS, Bakay R, et al. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med 2005;11:551-5.
81. Varenika V, Kells AP, Valles F, Hadaczek P, Forsayeth J, Bankiewicz KS. Controlled dissemination of AAV vectors in the primate brain. Prog Brain Res 2009;175:163-72.
82. Yin D, Forsayeth J, Bankiewicz KS. Optimized cannula design and placement for convection-enhanced delivery in rat striatum. J Neurosci Methods 2010;187:46-51.
83. Ying QL, Nichols J, Evans EP, Smith AG. Changing potency by spontaneous fusion. Nature 2002;416:545-8.
84. Yoon SH, Shim YS, Park YH, Chung JK, Nam JH, Kim MO, et al. Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: Phase I/II clinical trial. Stem Cells 2007;25:2066-73.
85. Zrinzo L, Foltynie T, Limousin P, Hariz MI. Reducing hemorrhagic complications in functional neurosurgery: A large case series and systematic literature review. J Neurosurg 2012;116:84-94.